Gross profit increased 12.3%
Gross profit changed +12.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross profit changed +12.3% from the comparable as-filed period.
Net income changed +31.1% from the comparable as-filed period.
Revenue changed +11.8% from the comparable as-filed period.
Stock-based compensation changed +96.0% from the comparable as-filed period.
Operating income changed +15.7% from the comparable as-filed period.
Selling, general & administrative changed +13.0% from the comparable as-filed period.
Cash & equivalents changed -6.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed +12 basis points from the comparable as-filed period.
Inventory changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating margin changed +28 basis points from the comparable as-filed period.
Research & development changed +4.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.